• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ESSENTIAL MEDICAL, INC. MANTA 14F; VASCULAR CLOSURE DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ESSENTIAL MEDICAL, INC. MANTA 14F; VASCULAR CLOSURE DEVICE Back to Search Results
Model Number 2156
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Diminished Pulse Pressure (2606)
Event Date 04/06/2023
Event Type  Injury  
Manufacturer Narrative
Qn# (b)(4).An investigation has been opened to review historical data and risk documentation a follow up report will be submitted after investigation.
 
Event Description
It was reported that: "absent pulses after manta deployment." additional information has been requested from the account and the complaint will be re-reviewed on receipt.
 
Event Description
It was reported that: "absent pulses after manta deployment." additional information has been requested from the account and the complaint will be re-reviewed on receipt.
 
Manufacturer Narrative
(b)(4).The device was not returned for investigation.No return product evaluation could be completed.The device lot history record review indicated during lot release of manta lot, a single device exhibited a high collagen deployment force of the collagen deployment specification.No other non-conformities related to this lot, therefore, supporting the device met material, assembly, and performance specifications prior to shipment.Based on the information submitted, following an undisclosed procedure, a 14f manta was deployed for closure.Absent pulses were present post-closure, although the procedure outcome was reported as completed with this device.After multiple unsuccessful attempts to obtain further information for this investigation, the root cause of this occlusion cannot be determined due to the insufficient information submitted for investigative purposes.The manta instructions for use lists potential adverse events related to the deployment of vascular closure devices including ischemia of the leg or stenosis of the femoral artery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MANTA 14F
Type of Device
VASCULAR CLOSURE DEVICE
Manufacturer (Section D)
ESSENTIAL MEDICAL, INC.
exton
Manufacturer (Section G)
ESSENTIAL MEDICAL, INC.
260 sierra drive
exton
Manufacturer Contact
elaine cully
3015 carrington mill blvd
morrisville, NC 27560
MDR Report Key16769325
MDR Text Key313582747
Report Number3010252479-2023-00077
Device Sequence Number1
Product Code MGB
UDI-Device Identifier00856279007079
UDI-Public00856279007079
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180025
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 04/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/19/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/15/2024
Device Model Number2156
Device Catalogue Number2156
Device Lot NumberMN2201481
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/06/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
NOT REPORTED; NOT REPORTED
Patient Age75 YR
Patient SexFemale
-
-